Table 1:
Candidate(s) | Study participants | Associated SNP(s) | P-values | OR | Nature of variant(s) | Mapped Gene(s) | Reference |
---|---|---|---|---|---|---|---|
| |||||||
rs2234693 and rs9340799 in ESR1 | 119 severe PE cases and 103 controls; Caucasian women from Hungary | homozygous T-A haplotype carriers of rs2234693 and rs9340799 | 0.003 | 4.36 | intronic | ESR1 | (Molvarec et al., 2007) |
rs1800629 in TNF-α, rs1800896 in IL-10, rs1800795 in IL-6, and rs2430561 in IFN-γ | 116 severe PE cases and 107 normotensive pregnant and 58 non-pregnant controls; women from Brazil | rs2430561 | <0.001 | not reported | intronic | IFN-γ | (Pinheiro et al., 2015) |
C3 selected as candidate gene after primary complement screen | Primary complement screen: 259 severe PE cases and 426 controls; women from Finland C3 candidate screen: 960 severe PE cases and 760 controls; women from Finland |
rs2287845 rs366510 rs2287848 |
0.038 0.039 0.041 |
1.158 1.158 1.155 |
intronic intronic intronic |
C3 C3 C3 |
(Lokki et al., 2017) |
STOX1 | 373 early-onset PE cases and 500 controls; Turkish women | rs1341667 | 0.03 | 1.45 | missense (Tyr153His) | STOX1 | (Pinarbasi et al., 2020) |
rs1800896, rs1800871, rs180072 in IL-10 | 177 early-onset PE cases and 182 controls; women from Mongolia | rs1800872 | 0.04 | 1.67 | promoter region | IL-10 | (Song and Zhong, 2015) |
rs1800629 in TNF-α | 14 PE cases and 12 controls; women from UK | rs1800629 | <0.05 | not reported | promoter region | TNF-α | (Chen et al., 1996) |
rs1799724 in TNF-α | 133 PE cases and 115 controls; women from Finland | rs1799724* | 0.03 | 0.45 | promoter region | TNF-α | (Heiskanen et al., 2002) |
rs2430561 in IFN-γ and rs1800896, rs1800871, and rs1800872 in IL-10 | 134 cases and 164 controls; women from Iran | rs1800896 | 0.045 | 1.45 | promoter region | IL-10 | (Kamali-Sarvestani et al., 2006) |
rs1800629 in TNF-α, rs1800795 in IL-6, rs1800896 in IL-10 | 101 cases and 95 controls; women from Turkey | rs1800896 | 0.04 | 1.52 | promoter region | IL-10 | (Vural et al., 2010) |
rs2243250 in IL-4, rs4986790 in TLR2, rs3918242 in MMP-9 | 117 PE cases and 146 controls; women from UK | rs2243250 | 0.055 | 1.534 | promoter region | IL-4 | (Fraser et al., 2008) |
71 SNPs in candidate genes (CXCR4, HNMT, KYNU, RPRM, ACVR1, ACVR1C, ACVR2A) at 2q22-23 locus on chromosome 2 | 1,139 PE cases and 2,269 controls; Norwegian women | rs1014064 rs17742134 rs1424941 rs2161983 rs3768687 rs3764955 |
0.0184 0.0214 0.0171 0.0196 0.0214 0.0327 |
0.86 1.17 1.18 0.86 0.86 0.87 |
intronic intronic intronic intronic intronic intronic |
ACVR2A ACVR2A ACVR2A ACVR2A ACVR2A ACVR2A |
(Roten et al., 2009) |